⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
Pomerantz LLP Highlights Class Action Filing Against aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
ATYR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of aTyr Pharma, Inc. to Contact the Firm Today!
accessnewswire.com
ATYR
Pomerantz LLP Calls Attention to Class Action Involving aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
Securities Lawsuit Alert: aTyr Pharma, Inc. (ATYR) - Contact Levi & Korsinsky Before December 8, 2025
accessnewswire.com
ATYR
ATYR LAWSUIT ALERT: Levi & Korsinsky Notifies aTyr Pharma, Inc. Investors - Lead Plaintiff Deadline December 8, 2025
accessnewswire.com
ATYR
Securities Class Action Lawsuit Filed Against aTyr Pharma, Inc. (ATYR) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
ATYR
aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman
prnewswire.com
ATYR
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit - ATYR
prnewswire.com
ATYR
Your Guide to the aTyr Pharma, Inc. Lawsuit - A SueWallSt Podcast From Levi & Korsinsky
accessnewswire.com
ATYR
Class Action Lawsuit Alert: Levi & Korsinsky Reminds aTyr Pharma, Inc. (ATYR) Investors of December 8, 2025 Deadline
accessnewswire.com
ATYR